Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584–90.
Article PubMed PubMed Central Google Scholar
He S, Li H, Cao M, Sun D, Lei L, Li N, et al. Trends and risk factors of lung cancer in China. Chin J Cancer Res. 2020;32:683–94.
Article PubMed PubMed Central Google Scholar
Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, et al. Global burden and trends of lung cancer incidence and mortality. Chin Med J. 2023;136:1583–90.
PubMed PubMed Central Google Scholar
Chan MV, Huo YR, Cao C, Ridley L. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol. 2021;31:5421–33.
Halaoui R, McCaffrey L. Rewiring cell polarity signaling in cancer. Oncogene. 2015;34:939–50.
Article CAS PubMed Google Scholar
Viloria-Petit AM, David L, Jia JY, Erdemir T, Bane AL, Pinnaduwage D, et al. A role for the TGFbeta-Par6 polarity pathway in breast cancer progression. Proc Natl Acad Sci USA 2009;106:14028–33.
Article CAS PubMed PubMed Central Google Scholar
Zhang K, Zhao H, Ji Z, Zhang C, Zhou P, Wang L, et al. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition. Oncogene. 2016;35:1271–82.
Article CAS PubMed Google Scholar
Liu P, Zhu C, Luo J, Lan S, Su D, Wang Q, et al. Par6 regulates cell cycle progression through enhancement of Akt/PI3K/GSK-3beta signaling pathway activation in glioma. FASEB J. 2020;34:1481–96.
Article CAS PubMed Google Scholar
Togawa A, Sfakianos J, Ishibe S, Suzuki S, Fujigaki Y, Kitagawa M, et al. Hepatocyte growth factor stimulated cell scattering requires ERK and Cdc42-dependent tight junction disassembly. Biochem Biophys Res Commun. 2010;400:271–7.
Article CAS PubMed PubMed Central Google Scholar
Elbediwy A, Zhang Y, Cobbaut M, Riou P, Tan RS, Roberts SK, et al. The Rho family GEF FARP2 is activated by aPKCiota to control tight junction formation and polarity. J Cell Sci. 2019;132:jcs223743.
Article CAS PubMed PubMed Central Google Scholar
Huang Y, Liu P, Luo J, Zhu C, Lu C, Zhao N, et al. Par6 enhances glioma invasion by activating MEK/ERK pathway through a LIN28/let-7d positive feedback loop. Mol Neurobiol. 2023;60:1626–44.
Article CAS PubMed Google Scholar
Lu Z, Yuan S, Ruan L, Tu Z, Liu H. Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial-mesenchymal transition via integrin beta1-ILK-SNAIL1 pathway in ovarian cancer. Cell Death Dis. 2022;13:304.
Article CAS PubMed PubMed Central Google Scholar
Soman A, Asha Nair S. Unfolding the cascade of SERPINA3: inflammation to cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188760.
Article CAS PubMed Google Scholar
Zhang Y, Tian J, Qu C, Peng Y, Lei J, Li K, et al. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells. Breast Cancer. 2021;28:859–73.
Lara-Velazquez M, Zarco N, Carrano A, Phillipps J, Norton ES, Schiapparelli P, et al. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma. Neuro Oncol. 2021;23:599–610.
Article CAS PubMed Google Scholar
Ko E, Kim JS, Bae JW, Kim J, Park SG, Jung G. SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC. Redox Biol. 2019;24:101217.
Article CAS PubMed PubMed Central Google Scholar
Zhou J, Zhu M, Wang Q, Deng Y, Liu N, Liu Y, et al. SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition. Commun Biol. 2023;6:695.
Article CAS PubMed PubMed Central Google Scholar
Santamaria M, Pardo-Saganta A, Alvarez-Asiain L, Di Scala M, Qian C, Prieto J, et al. Nuclear alpha1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells. Gastroenterology. 2013;144:818–28.e814.
Article CAS PubMed Google Scholar
Jin Y, Zhang Y, Huang A, Chen Y, Wang J, Liu N, et al. Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF‑kappaB in lung cancer. Int J Oncol. 2023;63:96.
Article PubMed PubMed Central Google Scholar
Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation. 2024;5:100625.
CAS PubMed PubMed Central Google Scholar
Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharm. 2024;181:362–74.
Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46.
Article CAS PubMed Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.
Article CAS PubMed Google Scholar
Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5.
Article CAS PubMed PubMed Central Google Scholar
Lo HL, Yee JK. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors. Curr Protoc Hum Genet. 2007;Chapter 12:Unit 12.7.
National Research Council. 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press.
Wu H, Leng X, Liu Q, Mao T, Jiang T, Liu Y, et al. Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma. Cancer Res. 2023;83:3131–44.
Article CAS PubMed Google Scholar
Kemphues KJ, Priess JR, Morton DG, Cheng NS. Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell. 1988;52:311–20.
Article CAS PubMed Google Scholar
Petrie RJ, Doyle AD, Yamada KM. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol. 2009;10:538–49.
Article CAS PubMed PubMed Central Google Scholar
Marques E, Klefstrom J. Par6 family proteins in cancer. Oncoscience. 2015;2:894–5.
Article PubMed PubMed Central Google Scholar
Ruan L, Shen Y, Lu Z, Shang D, Zhao Z, Lu Y, et al. Roles of partitioning-defective protein 6 (Par6) and its complexes in the proliferation, migration and invasion of cancer cells. Clin Exp Pharm Physiol. 2017;44:909–13.
Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res. 2008;68:8201–9.
留言 (0)